L3Harris Technologies
LHX
$299.67
+5.09%
L3Harris Technologies is a global aerospace and defense technology company that provides advanced communication systems, sensors, avionics, space-based systems, and unmanned aerial vehicles to military and government customers. As a top-tier defense prime contractor, it distinguishes itself through a broad portfolio spanning software-defined radios, electronic warfare, and mission-critical training services, positioning it as a key supplier for modernized warfare. The current investor narrative centers on the company's ability to capitalize on elevated global defense spending amid geopolitical tensions, particularly following the U.S. retaliatory strikes against Iran and the Pentagon's SHIELD contract, which have driven renewed interest in defense primes. However, the stock has faced significant headwinds in recent months, with a sharp pullback from its 52-week high raising questions about valuation support and near-term momentum.…
LHX
L3Harris Technologies
$299.67
Related headlines
Investment Opinion: Should I buy LHX Today?
Rating: Hold. L3Harris is a fundamentally sound defense prime with accelerating revenue growth and strong free cash flow, but the stock is in a deep technical downtrend with margin pressures that warrant caution. The consensus analyst rating is Buy with an average target of $378.17, implying 34% upside, but the stock's recent price action suggests the market is pricing in risks that may take time to resolve.
Supporting Evidence: Revenue growth accelerated to 11.9% YoY in Q1 2026, the fastest in recent quarters. The forward P/E of 20.7x is in line with the aerospace & defense sector average, while the price-to-sales ratio of 2.61x is below the 5-year average of ~3.0x, suggesting potential value. TTM free cash flow of $2.589B provides a 4.5% FCF yield, and the dividend yield of 1.58% is supported by a 56% payout ratio. However, the trailing P/E of 35.5x is elevated due to a recent earnings trough, and the PEG ratio of 4.26x indicates the stock is priced at a premium to its growth rate.
Risks & Conditions: The biggest risks are margin compression (gross margin down to 24.4%), negative quarterly FCF, and the stock's 19.5% three-month decline. This Hold would upgrade to Buy if the stock stabilizes above $300 and gross margins recover above 25%, or if the forward P/E compresses below 18x. It would downgrade to Sell if revenue growth decelerates below 5% or if the stock breaks below the 52-week low of $260.22. Overall, LHX appears fairly valued on a forward basis but overvalued on trailing metrics, making it a hold for patient investors willing to wait for operational improvements.
Sign up to view all
LHX 12-Month Price Forecast
L3Harris presents a mixed picture. The company's revenue growth is accelerating and well above the sector median, supported by strong defense tailwinds. Valuation on a forward basis is reasonable, but the trailing P/E and PEG ratio suggest the market is pricing in optimistic earnings growth. The stock's sharp decline despite bullish analyst consensus indicates a disconnect that could resolve either way. The neutral stance reflects the balance between solid fundamentals and negative technical momentum. An upgrade to bullish would require evidence of margin stabilization and a price recovery above $300, while a downgrade to bearish would follow a break below the 52-week low or a significant earnings miss.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on L3Harris Technologies's 12-month outlook, with a consensus price target around $375.11 and implied upside of +25.2% versus the current price.
Average Target
$375.11
0 analysts
Implied Upside
+25.2%
vs. current price
Analyst Count
—
covering this stock
Price Range
$285 - $443
Analyst target range
L3Harris is covered by 18 analysts, with a consensus recommendation of 'Buy' (mean rating 1.6 on a 1-5 scale where 1 is Strong Buy). The average price target is $378.17, implying approximately 34% upside from the current price of $282.01. The distribution leans bullish, with no sell ratings evident in the institutional ratings data, which includes recent affirmations of Outperform from Bernstein, Buy from Citigroup, and Overweight from Morgan Stanley and JP Morgan. The consensus sentiment is clearly positive, reflecting confidence in the defense spending cycle and the company's execution. The target range spans from a low of $285.00 to a high of $443.00, representing a wide spread of $158 (55% of the current price). The low target of $285 is just 1% above the current price, suggesting that even the most bearish analyst sees limited downside, while the high target of $443 implies 57% upside, likely assuming multiple expansion and accelerated growth from new programs like the SHIELD contract and autonomous systems. The wide range indicates high uncertainty, but the fact that the average target is well above the current price suggests analysts believe the recent selloff is overdone. Recent ratings actions have been stable, with no downgrades in the past six months, reinforcing the bullish consensus. However, the stock's sharp decline despite positive analyst sentiment highlights a disconnect between fundamental expectations and market pricing, which could present an opportunity if the company delivers on its guidance.
Bulls vs Bears: LHX Investment Factors
L3Harris presents a classic value-versus-momentum tension. On the bull side, the company benefits from robust defense spending tailwinds, accelerating revenue growth (11.9% YoY), and a consensus analyst target implying 34% upside. The forward P/E of 20.7x is reasonable for the sector, and strong TTM FCF of $2.589B supports financial stability. However, the bear case is equally compelling: the stock is in a deep downtrend, having lost 19.5% in three months, with margin compression and a negative FCF quarter raising red flags. The high PEG ratio of 4.26x suggests the market is pricing in perfection, while disruptive threats from private competitors add uncertainty. The single most important tension is whether the accelerating revenue growth and defense budget tailwinds can overcome the operational margin pressure and negative market momentum. If the company delivers on earnings expectations and stabilizes margins, the stock could re-rate higher; if not, further downside toward the 52-week low is likely. Currently, the bearish technicals and margin concerns slightly outweigh the bullish fundamentals, making this a high-risk, high-reward opportunity.
Bullish
- 34% Upside to Analyst Target: The average analyst price target is $378.17, implying 34% upside from the current $282.01. With 18 analysts covering and a consensus Buy rating (1.6 mean), the selloff appears overdone relative to fundamental expectations.
- Defense Spending Tailwinds Intact: Recent U.S. retaliatory strikes against Iran and the Pentagon's SHIELD contract have supercharged defense primes. L3Harris is a key vendor, and the administration's push to quadruple 'exquisite class' weaponry output provides a multi-year demand backdrop.
- Revenue Growth Accelerating to 11.9%: Q1 2026 revenue grew 11.9% YoY to $5.744B, accelerating from 2.5% in Q4 2025 and 6.9% in Q3 2025. Space & Airborne Systems ($2.99B) and Communication Systems ($1.855B) are driving growth, supported by elevated defense budgets.
- Forward P/E in Line with Peers: At 20.7x forward earnings, LHX trades in line with the aerospace & defense sector average of 20-25x. The trailing P/E of 35.5x is elevated due to a recent earnings trough, but the forward multiple suggests reasonable valuation if earnings recover as expected.
Bearish
- Sharp Downtrend with 19.5% 3-Month Decline: LHX has fallen 19.5% in three months and 9.9% in the last month, underperforming the S&P 500 by 24.2% over three months. The stock sits at just 74% of its 52-week range, near the low of $260.22, indicating persistent selling pressure.
- Margin Compression and Negative FCF Quarter: Gross margin fell to 24.4% in Q1 2026 from 25.6% in Q4 2025 and 26.4% in Q3 2025. Net margin dropped to 8.9% from 11.4% in Q2 2022. Additionally, Q1 2026 free cash flow was -$194M due to working capital outflows, a concerning sign.
- High PEG Ratio of 4.26x: The PEG ratio of 4.26x indicates the stock is priced at a significant premium to its expected earnings growth rate. This limits upside if growth disappoints and suggests the market is already pricing in optimistic assumptions.
- Disruptive Threat from Private Competitors: Private companies like Saronic are raising massive funding for robotic warships, potentially disrupting traditional defense contractors. The Navy's pivot to faster, cheaper autonomous vessels could erode L3Harris's market share in unmanned systems.
LHX Technical Analysis
L3Harris is in a pronounced downtrend, with the stock declining 19.5% over the past three months and 9.9% in the last month alone, despite a 6.2% gain over the past year. The current price of $282.01 sits at just 74% of its 52-week range (low $260.22, high $379.23), placing it deep in the lower quartile. This positioning near the 52-week low suggests the market is pricing in significant negative sentiment, but also raises the potential for a mean-reversion bounce if fundamentals hold. The stock's beta of 0.746 indicates it is less volatile than the broader market, yet its relative weakness versus the S&P 500 (which gained 4.7% over three months) underscores a sector-specific or company-specific selloff. Short-term momentum is decisively bearish: the 1-month price change of -9.9% and 3-month change of -19.5% show accelerating downside, diverging sharply from the 1-year gain of 6.2%. This divergence signals a potential trend reversal or at least a deep correction, as the stock has given back all its gains from earlier in the year. The RSI is not provided, but the persistent decline without a significant bounce suggests oversold conditions may be building. Key support lies at the 52-week low of $260.22, a break below which would signal further downside and potentially test the $250 level. Resistance is at the 52-week high of $379.23, and a recovery above $300 (recent breakdown level) would be needed to stabilize the chart. With a beta of 0.746, L3Harris is 25% less volatile than the S&P 500, meaning its moves are relatively muted, but the current drawdown of 25.5% from the high is substantial for a low-beta stock, indicating company-specific stress.
Beta
0.75
0.75x market volatility
Max Drawdown
-26.6%
Largest decline past year
52-Week Range
$263-$379
Price range past year
Annual Return
+11.2%
Cumulative gain past year
| Period | LHX Return | S&P 500 |
|---|---|---|
| 1m | +2.0% | +0.6% |
| 3m | -5.6% | +3.4% |
| 6m | -15.5% | +7.1% |
| 1y | +11.2% | +16.4% |
| ytd | -1.6% | +8.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
LHX Fundamental Analysis
Revenue growth has been solid but decelerating: the most recent quarter (Q1 2026) posted revenue of $5.744 billion, up 11.9% year-over-year, accelerating from the 2.5% growth in Q4 2025 and 6.9% in Q3 2025. However, the multi-quarter trend shows variability, with Q2 2025 growth of 2.4% and Q1 2025 growth of 7.4%. The revenue segments reveal that Space and Airborne Systems ($2.99B) and Communication Systems ($1.855B) are the primary growth drivers, while Integrated Mission Systems ($990M) is smaller. The 11.9% YoY growth in Q1 2026 is encouraging, but the sustainability depends on continued defense budget expansion and program execution. Profitability is solid but under pressure: net income in Q1 2026 was $512 million, with a net margin of 8.9%, down from 11.4% in Q2 2022 but stable sequentially. Gross margin was 24.4% in Q1 2026, slightly below the 25.6% in Q4 2025 and the 26.4% in Q3 2025, indicating some margin compression. Operating margin improved to 11.2% in Q1 2026 from 6.7% in Q4 2025, but remains below the 13.2% level seen in Q4 2024. The company is profitable with a trailing EPS of $2.74, but the net margin of 8.9% is modest for a defense prime, suggesting room for operational improvement. The balance sheet is moderately leveraged: debt-to-equity is 0.57, and the current ratio is 1.19, indicating adequate liquidity. Free cash flow (FCF) was negative $194 million in Q1 2026 due to working capital outflows, but trailing twelve-month FCF is $2.589 billion, providing a healthy FCF yield of approximately 4.5% relative to market cap. ROE is 8.2%, which is reasonable but not exceptional. The company generated $2.589 billion in FCF over the TTM, which covers its dividend (payout ratio 56%) and debt service, but the negative FCF in Q1 2026 warrants monitoring.
Quarterly Revenue
$5.7B
2026-04
Revenue YoY Growth
+11.9%
YoY Comparison
Gross Margin
24.4%
Latest Quarter
Free Cash Flow
$2.6B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is LHX Overvalued?
Since net income is positive ($512 million in Q1 2026), the primary valuation metric is the P/E ratio. The trailing P/E is 35.5x, while the forward P/E is 20.7x, implying the market expects significant earnings growth in the coming year. The gap between trailing and forward P/E (35.5x vs 20.7x) suggests that the market is pricing in a sharp earnings recovery, likely driven by defense spending tailwinds and margin expansion. Compared to the aerospace & defense industry average (not provided, but typically around 20-25x forward earnings), L3Harris's forward P/E of 20.7x appears roughly in line with the sector, though the trailing multiple is elevated due to recent earnings troughs. The PEG ratio of 4.26x indicates that the stock is priced at a premium to its expected earnings growth rate, which may limit upside if growth disappoints. Historically, L3Harris's trailing P/E has ranged from 21.5x (Q3 2023) to 63.4x (Q4 2023), with the current 35.5x near the middle of that range. The forward P/E of 20.7x is near the lower end of its historical forward multiple band, suggesting that the stock is not excessively expensive on a forward basis. The price-to-sales ratio of 2.61x is below the 5-year average of roughly 3.0x, indicating potential value. Overall, the valuation appears reasonable if the company can deliver the expected earnings growth, but the high trailing multiple and PEG ratio caution against aggressive optimism.
PE
35.5x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 22x~36x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: L3Harris's net margin of 8.9% in Q1 2026 is down from 11.4% in Q2 2022, indicating persistent margin compression. Gross margin fell to 24.4% from 26.4% a year earlier, while operating margin of 11.2% remains below the 13.2% level seen in Q4 2024. The company also reported negative free cash flow of -$194M in Q1 2026 due to working capital outflows, though TTM FCF remains healthy at $2.589B. Debt-to-equity of 0.57 is manageable, but the current ratio of 1.19 suggests limited liquidity buffer. Revenue concentration in Space & Airborne Systems ($2.99B, 52% of total) exposes the company to program-specific risks.
Market & Competitive Risks: The stock's 25.5% drawdown from its 52-week high, despite a low beta of 0.746, signals company-specific stress that may not be captured by market indices. The forward P/E of 20.7x is in line with peers, but the PEG ratio of 4.26x indicates the market is paying a premium for expected growth, leaving little room for error. Competitive disruption from private companies like Saronic, which is developing robotic warships, threatens L3Harris's unmanned systems franchise. Additionally, the Pentagon's SHIELD contract shifts procurement toward a competitive marketplace model, potentially increasing pricing pressure. The stock's relative strength versus the S&P 500 is deeply negative (-24.2% over 3 months), suggesting sector rotation or loss of investor confidence.
Worst-Case Scenario: In a severe downturn, continued margin erosion, program delays, or a broader defense spending slowdown could drive LHX to test its 52-week low of $260.22. If the company misses earnings estimates or guides lower, the stock could break below that level, potentially falling to $250 or lower. From the current price of $282.01, this represents a downside of approximately 8-11%. However, given the stock's low beta and the structural defense tailwinds, a full-blown crisis is less likely; the realistic worst case is a -8% decline to the 52-week low, with further downside limited by the analyst low target of $285 (just 1% above current price).
FAQ
The primary risks are: 1) Margin compression – gross margin fell to 24.4% in Q1 2026 from 26.4% a year earlier, and net margin is down to 8.9% from 11.4% in Q2 2022. 2) Negative free cash flow – Q1 2026 FCF was -$194M due to working capital outflows, though TTM FCF remains strong at $2.589B. 3) Competitive disruption – private companies like Saronic are developing robotic warships that could erode L3Harris's market share in unmanned systems. 4) Technical risk – the stock is in a downtrend, down 19.5% in three months, and a break below the 52-week low of $260.22 could trigger further selling. The most severe risk is a sustained margin decline that prevents earnings from meeting expectations, leading to multiple compression.
The 12-month outlook is balanced across three scenarios. The base case (50% probability) sees the stock recovering toward the analyst average target of $378, driven by steady defense spending and in-line earnings. The bull case (25% probability) targets $378-$443, fueled by geopolitical escalation and margin recovery. The bear case (25% probability) sees the stock testing $260-$285 if margins continue to compress or defense budgets are cut. The most likely scenario is the base case, assuming revenue growth moderates to 6-8% and margins stabilize. The AI assessment is neutral with medium confidence, reflecting the tension between strong fundamentals and negative technical momentum.
On a forward basis, LHX appears fairly valued with a P/E of 20.7x, in line with the aerospace & defense sector average of 20-25x. However, the trailing P/E of 35.5x is elevated due to a recent earnings trough, and the PEG ratio of 4.26x suggests the stock is priced at a premium to its expected earnings growth. The price-to-sales ratio of 2.61x is below the 5-year average of ~3.0x, indicating potential value. Overall, the market is pricing in a sharp earnings recovery; if that materializes, the stock is undervalued, but if growth disappoints, it could be overvalued. The wide gap between trailing and forward multiples (35.5x vs 20.7x) highlights the earnings growth expectations embedded in the stock.
L3Harris offers a compelling risk/reward at current levels, with the average analyst target implying 34% upside to $378.17. The forward P/E of 20.7x is in line with the sector, and revenue growth is accelerating at 11.9% YoY. However, the stock is in a deep downtrend, having lost 19.5% in three months, and faces margin compression (gross margin down to 24.4%). It is a good buy for investors with a 12-month horizon who believe the defense spending cycle will continue and that the company can stabilize margins. For short-term traders, the negative momentum poses significant risk. The biggest downside is a break below the 52-week low of $260.22, which would imply an 8% loss from the current price.
L3Harris is better suited for long-term investment (12+ months) given its low beta of 0.746, which indicates lower volatility than the market, and its role as a defense prime with multi-year contracts. The dividend yield of 1.58% provides a modest income stream. Short-term trading is risky due to the stock's 19.5% three-month decline and negative momentum; the stock is near its 52-week low and could continue to fall before stabilizing. A minimum holding period of 12 months is recommended to allow the defense spending cycle and margin recovery to play out. For patient investors, the forward P/E of 20.7x and analyst target upside of 34% offer an attractive entry point.